Guggenheim Capital LLC Cytokinetics Inc Put Options Transaction History
Guggenheim Capital LLC
- $10.6 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CYTK
# of Institutions
408Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$451 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$364 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$306 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$246 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$187 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $2.89B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...